Emily H. Liu

Emily H. Liu is a highly experienced research scientist with a strong background in oncology, cancer biology, and immunology. Liu has held prominent positions including Research Scientist Investigator at Kaiser Permanente, Director of Research at AccuraGen, and Director of R&D as well as Lead Scientist and Head of Genomic Assays at Vortex Biosciences, Inc. Additionally, Liu served as VP of R&D and Principal Scientist at CVI Pharmaceuticals Ltd. Academically, Liu completed a Postdoctoral Scholar program at Stanford University and earned a Ph.D. in Cancer Biology and Immunology from Peking Union Medical College.